Bruce L. Levine, Ph.D.

faculty photo
Barbara and Edward Netter Professor in Cancer Gene Therapy
Department: Pathology and Laboratory Medicine
Graduate Group Affiliations

Contact information
Center for Cellular Immunotherapies
Smilow 8-114
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-746-1481
B.A. (Major-Biology, Minor-History)
The University of Pennsylvania , 1984.
Ph.D. (Immunology and Infectious Diseases)
The Johns Hopkins University, 1992.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Immunology, Cell and Gene Therapy

Description of Other Expertise

Good Manufacturing Practices

Selected Publications

Myers RM, Li Y, Barz Leahy A, Barrett DM, Teachey DT, Callahan C, Fasano CC, Rheingold SR, DiNofia A, Wray L, Aplenc R, Baniewicz D, Liu H, Shaw PA, Pequignot E, Getz KD, Brogdon JL, Fesnak AD, Siegel DL, Davis MM, Bartoszek C, Lacey SF, Hexner EO, Chew A, Wertheim GB, Levine BL, June CH, Grupp SA, Maude SL.: Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia. J Clin Oncol Jun 2021.

Bernabei L, Tian L, Garfall AL, Melenhorst JJ, Lacey SF, Stadtmauer EA, Vogl DT, Gonzalez VE, Plesa G, Young RM, Waxman A, Levine BL, June CH, Milone MC, Cohen AD.: B-cell maturation antigen chimeric antigen receptor T-cell re-expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor-based combination therapy. British Journal of Haematology 193(4): 851-855, May 2021.

Tebas P, Jadlowsky JK, Shaw PA, Tian L, Esparza E, Brennan AL, Kim S, Naing SY, Richardson MW, Vogel AN, Maldini CR, Kong H, Liu X, Lacey SF, Bauer AM, Mampe F, Richman LP, Lee G, Ando D, Levine BL, Porter DL, Zhao Y, Siegel DL, Bar KJ, June CH, Riley JL.: CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication. Journal of Clinical Investigation 131(7): e144486, Apr 2021.

Agarwal S, Wellhausen N, Levine BL, June CH.: Production of Human CRISPR-Engineered CAR-T Cells. Journal of Visualized Experiments 169, Mar 2021.

Jacobson JM, Jadlowsky JK, Lacey SF, Fraietta JA, Plesa G, Chono H, Lee DH, Kulikovskaya I, Bartoszek C, Chen F, Tian L, Dimitri A, Levine BL, Veloso EA, Hwang WT, June CH.: Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals. Molecular Therapy 29(2): 626-635, February 2021.

Diorio C, Shaw PA, Pequignot E, Orlenko A, Chen F, Aplenc R, Barrett DM, Bassiri H, Behrens E, DiNofia AM, Gonzalez V, Koterba N, Levine BL, Maude SL, Meyer NJ, Moore JH, Paessler M, Porter DL, Bush JL, Siegel DL, Davis MM, Zhang D, June CH, Grupp SA, Melenhorst JJ, Lacey SF, Weiss SL, Teachey DT. : Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children. Blood Advances 4(20): 5174-5183, October 2020.

Andrew H Ko, Alexander C Jordan, Evan Tooker, Simon F Lacey, Renee B Chang, Yan Li, Alan P Venook, Margaret Tempero, Lloyd Damon, Lawrence Fong, Mark H O'Hara, Bruce L Levine, J Joseph Melenhorst, Gabriela Plesa, Carl H June, Gregory L Beatty: Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer. Molecular Therapy July 2020 Notes: online ahead of print, DOI: 10.1016/j.ymthe.2020.07.017.

Mark D Stewart, Anne Keane, Lisa H Butterfield, Bruce L Levine, Bruce Thompson, Yuan Xu, Chris Ramsborg, Ann Lee, Michael Kalos, Chin Koerner, Timothy Moore, Ingrid Markovic, Laura Lasiter, Ramy Ibrahim, Jeffrey Bluestone, Ellen Sigal, Jeff Allen: Accelerating the development of innovative cellular therapy products for the treatment of cancer. Cytotherapy 22(5): 239-246, May 2020.

Noelle V Frey, Saar Gill, Elizabeth O Hexner, Stephen Schuster, Sunita Nasta, Alison Loren, Jakub Svoboda, Edward Stadtmauer, Daniel J Landsburg, Anthony Mato, Bruce L Levine, Simon F Lacey, Jan Joseph Melenhorst, Elizabeth Veloso, Avery Gaymon, Edward Pequignot, Xinhe Shan, Wei-Ting Hwang, Carl H June, David L Porter: Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia. Journal of Clinical Oncology April 2020 Notes: online ahead of print DOI: 10.1200/JCO.19.03237.

Stadtmauer Edward A, Fraietta Joseph A, Davis Megan M, Cohen Adam D, Weber Kristy L, Lancaster Eric, Mangan Patricia A, Kulikovskaya Irina, Gupta Minnal, Chen Fang, Tian Lifeng, Gonzalez Vanessa E, Xu Jun, Jung In-Young, Melenhorst J Joseph, Plesa Gabriela, Shea Joanne, Matlawski Tina, Cervini Amanda, Gaymon Avery L, Desjardins Stephanie, Lamontagne Anne, Salas-Mckee January, Fesnak Andrew, Siegel Donald L, Levine Bruce L, Jadlowsky Julie K, Young Regina M, Chew Anne, Hwang Wei-Ting, Hexner Elizabeth O, Carreno Beatriz M, Nobles Christopher L, Bushman Frederic D, Parker Kevin R, Qi Yanyan, Satpathy Ansuman T, Chang Howard Y, Zhao Yangbing, Lacey Simon F, June Carl H: CRISPR-engineered T cells in patients with refractory cancer. Science (New York, N.Y.) Feb 2020.

back to top
Last updated: 08/05/2021
The Trustees of the University of Pennsylvania